Wednesday, October 7, 2020

Advanced prostate cancer has an unexpected weakness that can be targeted by drugs: Researchers identified that SUCLA2-deficient prostate cancer cells can be selectively treated with thymoquinone -- ScienceDaily

Advanced prostate cancer has an unexpected weakness that can be targeted by drugs: Researchers identified that SUCLA2-deficient prostate cancer cells can be selectively treated with thymoquinone -- ScienceDaily

No comments:

Post a Comment